FRONTPRO 3 CHEWABLE TABLETS FOR DOGS 25-50 KG

FRONTPRO® is the new antiparasitic in practical chewable tablets:

a tasty chewable tablet with targeted action against fleas and ticks, available without a veterinary prescription.

Indications: Treatment of flea infestations (Ctenocephalides felis and C. canis) in dogs, for at least 5 weeks.

Treatment of tick infestations (Dermacentor reticulatus, Ixodes ricinus, Rhipicephalus sang uineus) in dogs.

One treatment eliminates ticks for up to a month.

To be exposed to the active ingredient, fleas and ticks must attach to the host and begin a blood meal.

Directions for use and Dosage: For oral use. Dosage: The product should be administered at doses of 2.7 to 7 mg/kg of body weight as per the following schedule.

Dog's body weight: >25-50 kg;

dosage and number of chewable tablets to be administered; frontpro 136 mg: 1.

The tablets should not be divided.

Directions for use: The tablets are chewable and palatable to most dogs.

It is possible to administer the tablets with food if the dog does not accept taking them directly.

Treatment Program: Treatment of Flea and Tick Infestations:

For optimal control of flea and tick infestations, the product should be administered at intervals

monthly during periods of greatest seasonality for fleas and/or ticks, based on the local epidemiological situation.

Characteristics ACTIVE INGREDIENTS: Each chewable tablet contains, active ingredient.

Chewable tablets for dogs >25-50 kg; afoxolaner: 136 mg.

EXCIPIENTS: Maize starch, purified soy protein, braised beef flavour, povidone (E1201),

macrogol 400, macrogol 4000, macrogol 15 hydroxystearate, glycerol (E422), medium chain triglycerides.

Warnings: Do not use in cases of hypersensitivity to the active substance or to any of the excipients.

No adverse reactions were observed in healthy Beagle puppies older than 8 weeks treated with a dosage

equal to 5 times the maximum dose repeated 6 times at intervals of two to four weeks.

To allow parasites to be exposed to afoxolaner, they must initiate a blood meal on the host;

therefore the risk of transmission of diseases from the parasite cannot be excluded.

When treating parasite infestations, all animals in contact should be treated simultaneously with a suitable product.

Fleas, at any stage of growth, can infest your dog's bed and regular resting areas such as carpets and soft furnishings.

These areas, in case of massive flea infestations and at the beginning of the anti-parasitic treatment,

should be treated with a specific environmental product and then cleaned regularly with a vacuum cleaner.

Special precautions for use in animals: In the absence of available data, a veterinarian should be consulted before use.

treat puppies under 8 weeks of age and/or dogs weighing less than 2 kg.

Special precautions to be taken by the person administering the veterinary medicinal product to animals:

To prevent children from accessing the veterinary medicinal product, remove only one tablet at a time from the blister.

Place the blister with the remaining chewable tablets back in the box.

Wash hands after handling the product. No adverse reactions have been observed in healthy purebred puppies.

Beagles over 8 weeks of age treated with a dosage equal to 5 times

the maximum dose repeated 6 times at intervals of two to four weeks.

Main incompatibilities: not applicable.

Adverse Effects: Neurological signs (convulsions, ataxia and muscle tremors), pruritus, lethargy, anorexia

and mild gastrointestinal disturbances (vomiting, diarrhoea), have been reported very rarely.

Most reported adverse reactions were self-limiting and short-lived.

The frequency of adverse reactions is defined using the following conventions:

very common (more than 1 in 10 treated animals show adverse reactions);

common (more than 1 but less than 10 animals in 100 animals treated);

uncommon (more than 1 but less than 10 animals in 1,000 animals treated);

rare (more than 1 but less than 10 animals in 10,000 animals treated);

very rare (less than 1 animal in 10,000 animals treated, including isolated reports).

Pregnancy and Lactation: Laboratory studies performed in rats and rabbits have not highlighted the existence of teratogenic effects,

or any adverse reaction on the reproductive capacity of male and female subjects.

The safety of the veterinary medicinal product during pregnancy and lactation or in breeding dogs has not been established.

Consult a veterinarian before treatment during pregnancy and lactation or before use in breeding dogs.